Roll up the Sleeves! When the bell rang at previous close Evoke Pharma, Inc. (EVOK) was down -9.80%

Let’s start up with the current stock price of Evoke Pharma, Inc. (EVOK), which is $2.21 to be very precise. The Stock rose vividly during the last session to $2.45 after opening rate of $2.45 while the lowest price it went was recorded $2.1 before closing at $2.45.

Evoke Pharma, Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.79 on 05/26/20, with the lowest value was $0.50 for the same time period, recorded on 06/26/19.

Evoke Pharma, Inc. (EVOK) full year performance was 256.45%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Evoke Pharma, Inc. shares are logging -20.79% during the 52-week period from high price, and 341.91% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.50 and $2.79.

The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 917522 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Evoke Pharma, Inc. (EVOK) recorded performance in the market was 36.42%, having the revenues showcasing 142.86% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 54.01M, as it employees total of 5 workers.

Analysts verdict on Evoke Pharma, Inc. (EVOK)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.46, with a change in the price was noted +0.63. In a similar fashion, Evoke Pharma, Inc. posted a movement of +40.32% for the period of last 100 days, recording 337,313 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity. The total Debt to Equity ratio for EVOK is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Evoke Pharma, Inc. (EVOK): Technical Analysis

Raw Stochastic average of Evoke Pharma, Inc. in the period of last 50 days is set at 67.60%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 59.44%. In the last 20 days, the company’s Stochastic %K was 71.43% and its Stochastic %D was recorded 78.43%.

Let’s take a glance in the erstwhile performances of Evoke Pharma, Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 36.42%. Additionally, trading for the stock in the period of the last six months notably improved by 33.94%, alongside a boost of 256.45% for the period of the last 12 months. The shares increased approximately by 0.52% in the 7-day charts and went down by -4.74% in the period of the last 30 days. Common stock shares were driven by 142.86% during last recorded quarter.